Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: Relationship of TNM and IASLC/ATS/ERS classifications

Lung Cancer

Volumn 85, Issue 2, 2014, Pages 270-275

  Ito, Masaoki ^a   Miyata, Yoshihiro ^a   Kushitani, Kei ^b   Yoshiya, Tomoharu ^a   Mimae, Takahiro ^a   Ibuki, Yuta ^a   Misumi, Keizo ^a   Takeshima, Yukio ^b   Okada, Morihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; In situ; Invasive; Lung cancer; Prognosis; Recurrence; Tumor staging

Indexed keywords

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR INVASION; TUMOR VOLUME; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; LUNG NEOPLASMS; LUNG RESECTION; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84904089190     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.05.014     Document Type: Article

References (22)

1. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., et al. International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
2. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
3. Goldstaw P. Staging manual in thoracic oncology 2009, 39. Editorial Rx Press Orange Park, Orange Park, FL.
4. Zell J.A., Ignatius Ou S.H., Ziogas A., Anton-Culver H. Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry. J Thorac Oncol 2007, 2:1078-1085.
5. Kameyama K., Takahashi M., Ohata K., Igai H., Yamashina A., Matsuoka T., et al. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution. J Thorac Cardiovasc Surg 2009, 137:1180-1184.
6. Ruffini E., Filosso P.L., Bruna M.C., Coni F., Cristofori R.C., Mossetti C., et al. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience. Eur J Cardiothorac Surg 2009, 36:1037-1044.
7. Fibla J.J., Cassivi S.D., Decker P.A., Allen M.S., Darling G.E., Landreneau R.J., et al. Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030). Eur J Cardiothorac Surg 2013, 43:911-914. ACOSOG Z0030 Study Group.
8. Yoshizawa A., Motoi N., Riely G.J., Sima C.S., Gerald W.L., Kris M.G., et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011, 24:653-664.
9. Yoshizawa A., Sumiyoshi S., Sonobe M., Kobayashi M., Fujimoto M., Kawakami F., et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013, 8:52-61.
10. Zhang J., Wu J., Tan Q., Zhu L., Gao W. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: A clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification. J Thorac Oncol 2013, 8:1196-1202.
11. Russell P.A., Wainer Z., Wright G.M., Daniels M., Conron M., Williams R.A. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011, 6:1496-1504.
12. Kato H., Ichinose Y., Ohta M., Hata E., Tsubota N., Tada H., et al. Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004, 350:1713-1721.
13. Hamada C., Tsuboi M., Ohta M., Fujimura S., Kodama K., Imaizumi M., et al. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials. J Thorac Oncol 2009, 4:1511-1516.
14. Kato F., Hamasaki M., Miyake Y., Iwasaki A., Iwasaki H., Nabeshima K. Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung. Lung Cancer 2012, 77:495-500.
15. Tsutani Y., Miyata Y., Mimae T., Kushitani K., Takeshima Y., Yoshimura M., et al. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma. J Thorac Cardiovasc Surg 2013, 146:580-585.
16. Borczuk A.C., Qian F., Kazeros A., Eleazar J., Assaad A., Sonett J.R., et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 2009, 33:462-469.
17. Yanagawa N., Shiono S., Abiko M., Ogata S.Y., Sato T., Tamura G. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma. J Thorac Oncol 2013, 8:612-618.
18. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852.
19. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
20. Leslie H., Sobin, Mary K., Gospodarowicz Christian Wittekind. The TNM classification of malignant tumours 2009, Wiley-Blackwell. 7th ed.
21. Warth A., Muley T., Meister M., Stenzinger A., Thomas M., Schirmacher P., et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012, 30(May (13)):1438-1446.
22. Sica G., Yoshizawa A., Sima C.S., Azzoli C.G., Downey R.J., Rusch V.W., et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010, 34(August (8)):1155-1162.